METASTATIC

Clinical trials for METASTATIC explained in plain language.

Never miss a new study

Get alerted when new METASTATIC trials appear

Sign up with your email to follow new studies for METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3

Radioactive bullet targets deadly eye cancer in first human test

Disease control Ongoing

This early-stage study tests a radioactive drug called 225Ac-MTI-201 in 16 people with advanced uveal melanoma (a rare eye cancer) that has spread to other organs. The main goal is to find the safest dose and understand side effects. Participants must have already tried at least …

Matched conditions: METASTATIC

Phase: PHASE1 • Sponsor: Modulation Therapeutics, Inc. • Aim: Disease control

Last updated May 17, 2026 00:32 UTC

METASTATIC

Get alerted when new METASTATIC trials appear

Radioactive bullet targets deadly eye cancer in first human test